152 related articles for article (PubMed ID: 24402158)
1. Serial measurement of the circulating levels of tumour necrosis factor and its soluble receptors 1 and 2 for monitoring leprosy patients during multidrug treatment.
Costa RD; Mendonça VA; Soriani FM; Lyon S; Penido RA; Costa AM; Costa MD; Terra Fde S; Teixeira MM; Antunes CM; Teixeira AL
Mem Inst Oswaldo Cruz; 2013 Dec; 108(8):1051-6. PubMed ID: 24402158
[TBL] [Abstract][Full Text] [Related]
2. The role of tumour necrosis factor alpha and soluble tumour necrosis factor alpha receptors in the symptomatology of schizophrenia.
Turhan L; Batmaz S; Kocbiyik S; Soygur AH
Nord J Psychiatry; 2016 Jul; 70(5):342-50. PubMed ID: 26754110
[TBL] [Abstract][Full Text] [Related]
3. Soluble tumor necrosis factor receptors and heart failure risk in older adults: Health, Aging, and Body Composition (Health ABC) Study.
Marti CN; Khan H; Mann DL; Georgiopoulou VV; Bibbins-Domingo K; Harris T; Koster A; Newman A; Kritchevsky SB; Kalogeropoulos AP; Butler J;
Circ Heart Fail; 2014 Jan; 7(1):5-11. PubMed ID: 24323631
[TBL] [Abstract][Full Text] [Related]
4. [Changes in concentrations of tumor necrosis factor TNF and its soluble receptors type 1 (sTNF-r1) and type 2 (sTNF-R2) in serum of patients with ST-segment elevation myocardial infarction].
Mielczarek-Palacz A; Sikora J; Kondera-Anasz Z; Smycz M
Wiad Lek; 2011; 64(2):71-4. PubMed ID: 22026268
[TBL] [Abstract][Full Text] [Related]
5. Circulating TNF receptor 2 is closely associated with the kidney function in non-diabetic Japanese subjects.
Kurashina T; Nagasaka S; Watanabe N; Yabe D; Sugi N; Nin K; Hosokawa M; Nomura Y; Fukushima M; Nakai Y; Nishimura F; Taniguchi A
J Atheroscler Thromb; 2014; 21(7):730-8. PubMed ID: 24717758
[TBL] [Abstract][Full Text] [Related]
6. Increased tumor necrosis factor receptor 1 expression in human colorectal adenomas.
Hosono K; Yamada E; Endo H; Takahashi H; Inamori M; Hippo Y; Nakagama H; Nakajima A
World J Gastroenterol; 2012 Oct; 18(38):5360-8. PubMed ID: 23082052
[TBL] [Abstract][Full Text] [Related]
7. Systemic soluble tumor necrosis factor receptors 1 and 2 are associated with severity of diabetic retinopathy in Hispanics.
Kuo JZ; Guo X; Klein R; Klein BE; Cui J; Rotter JI; Ipp E; Chen YD
Ophthalmology; 2012 May; 119(5):1041-6. PubMed ID: 22330960
[TBL] [Abstract][Full Text] [Related]
8. Serum soluble TNF receptor I and II levels correlate with disease activity in IBD patients.
Spoettl T; Hausmann M; Klebl F; Dirmeier A; Klump B; Hoffmann J; Herfarth H; Timmer A; Rogler G
Inflamm Bowel Dis; 2007 Jun; 13(6):727-32. PubMed ID: 17260368
[TBL] [Abstract][Full Text] [Related]
9. Correlation of higher levels of soluble TNF-R1 with a shorter survival, independent of age, in recurrent glioblastoma.
Ahluwalia MS; Bou-Anak S; Burgett ME; Sarmey N; Khosla D; Dahiya S; Weil RJ; Bae E; Huang P; McGraw M; Grove LM; Olman MA; Prayson RA; Suh JH; Gillespie GY; Barnholtz-Sloan J; Nowacki AS; Barnett GH; Gladson CL
J Neurooncol; 2017 Feb; 131(3):449-458. PubMed ID: 27858267
[TBL] [Abstract][Full Text] [Related]
10. Soluble tumor necrosis factor alpha receptors in sera from leprosy patients.
Munk ME; Anding P; Schettini AP; Cunha MG; Kaufmann SH
Infect Immun; 1999 Jan; 67(1):423-5. PubMed ID: 9864247
[TBL] [Abstract][Full Text] [Related]
11. Proinflammatory cytokine activation is linked to apoptotic mediator, soluble Fas level in patients with chronic heart failure.
Kinugawa T; Kato M; Yamamoto K; Hisatome I; Nohara R
Int Heart J; 2012; 53(3):182-6. PubMed ID: 22790687
[TBL] [Abstract][Full Text] [Related]
12. Three measures of tumor necrosis factor alpha activity and insulin resistance in nonobese Japanese type 2 diabetic patients.
Ohya M; Taniguchi A; Fukushima M; Nakai Y; Kawasaki Y; Nagasaka S; Kuroe A; Taki Y; Yoshii S; Hosokawa M; Inagaki N; Seino Y
Metabolism; 2005 Oct; 54(10):1297-301. PubMed ID: 16154427
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of TNF-alpha and its soluble receptors in the plasma of patients with epithelial ovarian cancer.
Dobrzycka B; Terlikowski SJ; Kowalczuk O; Kinalski M
Eur Cytokine Netw; 2009 Sep; 20(3):131-4. PubMed ID: 19825522
[TBL] [Abstract][Full Text] [Related]
14. Elevation of serum soluble tumour necrosis factor receptors in patients with polymyositis and dermatomyositis.
Shimizu T; Tomita Y; Son K; Nishinarita S; Sawada S; Horie T
Clin Rheumatol; 2000; 19(5):352-9. PubMed ID: 11055823
[TBL] [Abstract][Full Text] [Related]
15. Lack of soluble TNF-receptors in women with recurrent spontaneous abortion and possibility for its correction.
Chernyshov VP; Vodyanik MA; Pisareva SP
Am J Reprod Immunol; 2005 Nov; 54(5):284-91. PubMed ID: 16212650
[TBL] [Abstract][Full Text] [Related]
16. Chronological changes in circulating levels of soluble tumor necrosis factor receptors 1 and 2 in rats with carbon tetrachloride-induced liver injury.
Ijiri Y; Kato R; Sadamatsu M; Takano M; Okada Y; Tanaka K; Hayashi T
Toxicology; 2014 Feb; 316():55-60. PubMed ID: 24389507
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the expression of interleukin 1 beta (IL-1beta) and interleukin 1 receptor antagonist (IL-1Ra) in leprosy patients.
Costa RD; Mendonça VA; Lyon S; Penido RA; Costa AM; Costa MD; Nishi MP; Teixeira MM; Teixeira AL; Antunes CM
Rev Soc Bras Med Trop; 2008; 41 Suppl 2():99-103. PubMed ID: 19618085
[TBL] [Abstract][Full Text] [Related]
18. [Tumor necrosis factor alpha (TNF-alpha) and its receptors: sTNF-alphaRI i sTNF-alphaRII in chronic pancreatitis].
Daniel P; Mokrowiecka A; Gasiorowska A; Małecka-Panas E
Pol Arch Med Wewn; 2005 Jul; 114(1):639-43. PubMed ID: 16466009
[TBL] [Abstract][Full Text] [Related]
19. Early detection of increased tumour necrosis factor alpha (TNFalpha) and soluble TNF receptor protein plasma levels after trauma reveals associations with the clinical course.
Spielmann S; Kerner T; Ahlers O; Keh D; Gerlach M; Gerlach H
Acta Anaesthesiol Scand; 2001 Mar; 45(3):364-70. PubMed ID: 11207475
[TBL] [Abstract][Full Text] [Related]
20. Concentrations of tumour necrosis factor-α and its soluble receptors in the serum of teenagers with atherosclerosis risk factors: obesity or obesity combined with hypertension.
Obuchowicz A; Kniażewska M; Zmudzińska-Kitczak J; Urban K; Gonciarz-Majda A
J Pediatr Endocrinol Metab; 2014 Nov; 27(11-12):1209-12. PubMed ID: 25153572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
